<?xml version="1.0" encoding="UTF-8"?>
<p>A booster dose may be unnecessary in immunocompetent patients with IBD, even though protective titers of anti-HBs wane during follow-up. Long-term follow-up studies have demonstrated that immune memory persists in immunocompetent individuals, even though anti-HBs levels decline [
 <xref rid="b79-ir-2019-09155" ref-type="bibr">79</xref>].
</p>
